Neurocentria, Inc.
Patent owner in reexamination·3 ex parte reexams
Neurocentria, Inc.'s patents have been the subject of 3 USPTO ex parte reexaminations, with 3 currently open. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
125
226
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/016,499 | Jul 29, 2026 | 8,470,352 | Magnesium Compositions and Uses Thereof for Metabolic Disorders | — | Open |
| 90/016,373 | Jun 3, 2026 | — | MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS | — | Open |
| 90/015,776 | Dec 12, 2025 | 8,637,061 | MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS | — | Open |
See the full reexam picture for Neurocentria, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.